Medpharm Holdings, LLC
Records under this name other than the patents Medpharm Holdings, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Back to Medpharm Holdings, LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,808,539 | Hypoosmotic Solutions for Lymph Node Detection Formerly held In force · High confidence | In force | High confidence | |
| US 10,722,499 | ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE Formerly held In force · High confidence | In force | High confidence | |
| US 11,135,204 | ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE Formerly held In force · High confidence | In force | High confidence | |
| US 12,268,673 | ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,329,748 | Anhydrous compositions of mTOR inhibitors and methods of use Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,000,513 | Anhydrous compositions of mTOR inhibitors and methods of use Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,679,101 | ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE Formerly held In force · Low confidence | In force | Low confidence | |
| US 12,005,067 | Jak Inhibitor with a Vitamin D Analog for Treatment of Skin Diseases Formerly held In force · High confidence | In force | High confidence | |
| US 12,310,950 | Formulations of pyrrolopyridine-aniline compounds Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,980,983 | Peroxide Formulations and Methods and Applicators for Using the Same Formerly held Lapsed on the fee record Ended May 29, 2026 · High confidence | Lapsed on the fee record | Ended May 29, 2026 | High confidence |